Microbix Biosystems Inc.
MBX.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -28.82% | -29.00% | -12.08% | -7.44% | 1.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -28.82% | -29.00% | -12.08% | -7.44% | 1.28% |
| Cost of Revenue | -13.49% | -15.11% | -9.14% | -14.33% | 0.54% |
| Gross Profit | -40.83% | -38.02% | -14.29% | -1.64% | 1.88% |
| SG&A Expenses | 7.10% | -6.64% | -5.58% | -10.90% | -12.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.74% | -9.27% | -6.19% | -11.06% | -4.93% |
| Operating Income | -245.91% | -138.07% | -70.35% | 53.22% | 133.54% |
| Income Before Tax | -307.56% | -162.12% | -103.40% | -58.69% | -45.14% |
| Income Tax Expenses | -136.68% | -136.68% | -- | -- | -- |
| Earnings from Continuing Operations | -321.07% | -163.20% | -106.34% | -62.36% | -49.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -321.07% | -163.20% | -106.34% | -62.36% | -49.16% |
| EBIT | -245.91% | -138.07% | -70.35% | 53.22% | 133.54% |
| EBITDA | -151.17% | -97.08% | -43.13% | 32.24% | 73.55% |
| EPS Basic | -319.80% | -162.23% | -105.47% | -62.56% | -49.75% |
| Normalized Basic EPS | -304.35% | -160.48% | -98.39% | 72.73% | 228.57% |
| EPS Diluted | -329.29% | -165.96% | -107.30% | -62.96% | -50.00% |
| Normalized Diluted EPS | -304.35% | -160.48% | -98.39% | 72.73% | 228.57% |
| Average Basic Shares Outstanding | 1.14% | 0.11% | 1.46% | 0.65% | 0.02% |
| Average Diluted Shares Outstanding | 0.57% | -0.22% | 1.39% | 0.87% | -0.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |